Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can learning to accept pain ease suffering? new study investigates

NCT ID NCT07067619

Symptom relief Sponsor: University of Haifa Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a pain acceptance training program for adults with chronic pain and emotional distress. The training uses dialectical thinking to help participants accept pain while still wanting it to end. Researchers will measure changes in pain levels, self-efficacy, and depression in 100 participants.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pain acceptance training (behavioral intervention)
What this could lead to
If it works, this could offer a new way to manage chronic pain and emotional distress without medication.
What could go wrong
This is a small, early-stage study with no control group, so results may not be widely applicable. The intervention is behavioral, so benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Men and Women 2. Aged 18-70 3. Able to provide a signed informed consent 4. Experiencing significant pain symptoms that interfere with daily-life functioning 5. Experiencing significant emotional distress symptoms Exclusion Criteria: Patients under the age of 18 and/or diagnosed with one or more of the following diagnoses will be excluded from participation in the study: 1. Patients rating their average pain in the last week and in the last month as less than 3 in a 0-10 numerical rating scale (i.e. NPS) 2. Patients rating their emotional distress levels as less than 25 in a 10-50 numerical rating scale (i.e. Kessler Psychological Distress Scale \[K10\]) 3. Patients diagnosed with psychotic disorders and/or suffering from psychotic symptoms. 4. Patients diagnosed with Autism Spectrum disorder. 5. Patients diagnosed with Intellectual disability. 6. Patients diagnosed with eating disorders. 7. Patients with Immediate suicidal risk. 8. Patients who initiated a new drug and/or psychotherapy treatment within the last month. 9. Pregnant women. 10. Patients currently serving in the IDF.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome Nociceptive Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pain Comorbid pain and emotional difficulties Somatic pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Psychiatric Division, Rambam Health Care Campus

    RECRUITING

    Haifa, 3109601, Israel

  • University of Haifa

    RECRUITING

    Haifa, 3498838, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.